Determination of [35S]guanosine-5'-O'(3-thio)triphosphate binding mediated by cholinergic muscarinic receptors in membranes from Chinese hamster ovary cells and rat striatum using an anti-G protein scintillation proximity assay

Journal of Pharmacology and Experimental Therapeutics

Volumn 289, Issue 2, 1999, Pages 946-955

  DeLapp, Neil W ^a   McKinzie, Jamie H ^a   Sawyer, Barry D ^a   Vandergriff, Amy ^a   Falcone, Julie ^a   McClure, Don ^a   Felder, Christian C ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); MUSCARINIC RECEPTOR; OTENZEPAD; PERTUSSIS TOXIN; PIRENZEPINE; SULFUR 35; DRUG DERIVATIVE; MUSCARINIC AGENT; MUSCARINIC M1 RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; OXOTREMORINE;

ANIMAL CELL; CHO CELL; CHOLINERGIC STIMULATION; CONCENTRATION RESPONSE; CONFERENCE PAPER; CORPUS STRIATUM; DRUG POTENCY; DRUG RECEPTOR BINDING; IMMUNOPRECIPITATION; MEMBRANE BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN PROTEIN INTERACTION; SCINTILLATION; ALGORITHM; ANIMAL; ARTICLE; CELL MEMBRANE; DRUG EFFECT; HAMSTER; IMMUNOLOGY; METABOLISM; METHODOLOGY; MOUSE; NEOSTRIATUM; RAT; SERODIAGNOSIS;

ALGORITHMS; ANIMALS; ANTIBODIES; CELL MEMBRANE; CHO CELLS; CRICETINAE; GTP-BINDING PROTEINS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); MICE; MUSCARINIC AGONISTS; MUSCARINIC ANTAGONISTS; NEOSTRIATUM; OXOTREMORINE; PIRENZEPINE; PRECIPITIN TESTS; RATS; RECEPTOR, MUSCARINIC M1; RECEPTORS, MUSCARINIC;

EID: 0032586641     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (23)

1. Alper RH and Nelson DL (1998) Characterization of 5-HT1A receptor-mediated [35S]GTPγS binding in rat hippocampal membranes. Eur J Pharmacol 343:303-312.
2. Barr AJ, Brass LF and Manning DR (1997) Reconstitution of receptors and GTP-binding regulatory proteins (G proteins) in Sf9 cells. A direct evaluation of selectivity in receptor-G protein coupling. J Biol Chem 272:2223-2229.
3. Burford NT, Tobin AB and Nahorski SR (1995) Coupling of muscarinic m1, m2, and m3 acetylcholine receptors, expressed in Chinese hamster ovary cells, to pertussis toxin-sensitive/insensitive guanine nucleotide-binding proteins. Eur J Pharmacol 289:343-351.
4. DeLapp NW, Eckols K and Shannon HE (1996) Muscarinic agonist inhibition of rat striatal adenylate cyclase is enhanced by dopamine stimulation. Life Sci 59:565-572.
5. Dorje F, Wess J, Lambrecht G, Tacke R, Mutschler E and Brann MR (1990) Antagonist binding profiles of five cloned human muscarinic receptor subtypes. J Pharmacol Exp Ther 256:727-732.
6. Ehlert FJ, Delen FM, Yun SH, Friedman DJ and Self DW (1989) Coupling of subtypes of the muscarinic receptor to adenylate cyclase in the corpus striatum and heart. J Pharmacol Exp Ther 259:680-686.
7. Hilf G, Gierschik P and Jakobs KH (1989) Muscarinic acetylcholine receptor-stimulated binding of guanosine 5′-O-(3-thiotriphosphate) to guanine-nucleotide-binding proteins in cardiac membranes. Eur J Pharmacol 186:725-731.
8. Kaziro Y, Itoh H, Kozasa T, Nakafuku M and Satoh T (1991) Structure and function of signal-transducing GTP-binding proteins. Ann Rev Biochem 60:349-400.
9. 35S]-GTPγS binding mediated by human muscarinic m1-m4 receptors: Antagonist studies. Br J Pharmacol 109:1120-1127.
10. Leff P and Dougall IG (1993) Further concerns over Cheng-Prusoff Analysis. Trends Pharmacol Sci 14:110-113.
11. Levey AI, Kitt CA, Simonds WF, Price DL and Brann MR (1991) Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies. J Neurosci 11:3218-3226.
12. Migeon JC, Thomas SL and Nathanson NM (1995) Differential coupling of m2 and m4 muscarinic receptors to inhibition of adenylyl cyclase by Giα and Goα subunits. J Biol Chem 270:16070-16074.
13. McKinney M, Anderson D and Vella-Rountree L (1989) Different agonist-receptor active conformations for rat brain m1 and m2 muscarinic receptors that are separately coupled to two biochemical effector systems. Mol Pharmacol 35:39-47.
14. 2 muscarinic receptors using selective antagonists: Comparison with N1E-115 muscarinic receptors. J Pharmacol Exp Ther 257:1121-1129.
15. Murthy KS and Makhlouf GM (1996) Opioid μ, δ, and κ receptor-induced activation of phospholipase C-β3 and inhibition of adenylyl cyclase is mediated by Gi2 and Go in smooth muscle. Mol Pharmacol 50:870-877.
16. Offermanns S, Wieland T, Homann D, Sandman J, Bombien E, Spicher K, Schultz G and Jakobs KH (1994) Transfected muscarinic acetylcholine receptors selectively couple to Gi-type G proteins and Gq/11. Mol Pharmacol 45:890-898.
17. Okamoto T, Ikezu T, Murayama Y, Ogata E and Nishimoto I (1992) Measurement of GTPγS binding to specific G proteins in membranes using G-protein antibodies. FEBS Lett 305:125-138.
18. Olianas MC and Onali P (1991) Muscarinic stimulation of adenylate cyclase activity of rat olfactory bulb. II. Characterization of the antagonist sensitivity and comparison with muscarinic inhibitions of the enzyme in striatum and heart. J Pharmacol Exp Ther 259:680-686.
19. 35S] thiotriphosphate) binding by cholinergic muscarinic receptors in membranes of rat olfactory bulb. J Neurochem 67:2549-2556.
20. Olianas MC, Adem A, Karlsson E and Onali P (1996) Rat striatal muscarinic receptors coupled to the inhibition of adenylyl cyclase activity: Potent block by the selective m4 ligand muscarinic toxin 3 (MT3). Br J Pharmacol 118:283-288.
21. Purkerson SL and Potter LT (1998) Use of antimuscarinic toxins to facilitate studies of striatal m4 muscarinic receptors. J Pharmacol Exp Ther 284:707-713.
22. Reever CM, Ferrari-Dileo G and Flynn DD (1995) An immunoprecipitation strategy to examine specific muscarinic receptor-G protein interactions in membranes. Life Sci 56:1032.
23. Smith PK, Krohn RI, Hermanson GT, Malia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ and Klenk DC (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150:76-85.